Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance

BACKGROUND: Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting. RESULTS: A total of 108 archival samples which were from surgically resected oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kwang-Yu, Tsai, Shan-Yin, Chen, Shang-Hung, Tsou, Hsiao-Hui, Yen, Chia-Jui, Liu, Ko-Jiunn, Fang, Hsun-Lang, Wu, Hung-Chang, Chuang, Bin-Fay, Chou, Shao-Wen, Tang, Careen K, Liu, Shyun-Yeu, Lu, Pei-Jung, Yen, Ching-Yu, Chang, Jang-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710269/
https://www.ncbi.nlm.nih.gov/pubmed/23806066
http://dx.doi.org/10.1186/1423-0127-20-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710269/
https://www.ncbi.nlm.nih.gov/pubmed/23806066
http://dx.doi.org/10.1186/1423-0127-20-43

Ejemplares similares